We see 2228.HK stock trading at HK$9.89 pre-market on 17 Mar 2026 with volume at 47,386,783 shares. That price sits below the 50-day average of HK$11.41 and near the 200-day average of HK$9.60. Investors will watch the upcoming earnings release on 25 Mar 2026. Our piece connects model-led AI forecasts with fundamentals to frame short-term trading and medium-term AI sector positioning for XtalPi Holdings Limited on the HKSE.
Quick snapshot: 2228.HK stock pricing and market metrics
XtalPi Holdings Ltd (2228.HK) trades on the HKSE in HKD at HK$9.89. Market capitalization equals HK$40,882,031,730.00 and shares outstanding are 4,303,371,761.00. The 52-week range runs from HK$3.85 to HK$15.12. Recent intraday range shows a low of HK$9.31 and a high of HK$9.94. Average daily volume is 68,993,932.00 and today’s volume is 47,386,783.00.
Fundamentals and valuation for 2228.HK stock
XtalPi reports EPS HK$1.04 and a trailing P/E near 9.13 based on the full-quote snapshot. Price-to-book ratio sits at 4.50. Revenue per share is HK$0.18 and net income per share is HK$-0.05. The company shows strong liquidity with a current ratio of 9.69 and cash per share of HK$0.92. These figures reflect an AI-driven healthcare services firm investing heavily in R&D, which supports a premium P/S and elevated PB relative to peers.
Technicals and trading context for 2228.HK stock
Momentum indicators show pressure. RSI reads 33.59, Stochastic %K is 20.85, and MACD histogram is -0.03. Bollinger Bands middle band sits at HK$10.34. ATR is HK$0.50, signifying moderate intraday swings. The stock’s one-month decline is -15.25% while the one-year gain is 44.60%. Traders should note the ADX at 33.40, which indicates a strong trend, and on‑balance volume at 504,382,001.00.
Meyka AI rates 2228.HK with a score out of 100 and forecast
Meyka AI rates 2228.HK with a score out of 100. The proprietary score is 63.08 / 100, grade B, suggestion HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly price of HK$9.26, a quarterly price of HK$11.76, and a yearly price of HK$10.66. Versus the current HK$9.89, the model implies -6.37% monthly, +18.91% quarterly, and +7.74% yearly moves. Forecasts are model-based projections and not guarantees.
Catalysts, earnings and sector context for 2228.HK stock
Key catalysts include the earnings announcement on 25 Mar 2026, new AI partnerships, and clinical progress in drug discovery programs. The Healthcare sector on the Hong Kong market shows a one‑year performance of +29.63%, while tech-linked healthcare names face valuation scrutiny. Positive trial readouts or commercial deals could re-rate XtalPi; weaker bookings or slower uptake would weigh on sentiment.
Risks and trading strategy for 2228.HK stock
Primary risks include long receivable cycles with days sales outstanding at 268.35, negative operating cash flow per share at HK$-0.11, and a net income per share of HK$-0.05. Valuation metrics such as price-to-sales at 52.87 signal investor expectations for high growth. For active traders, consider tight stop losses near HK$9.00 and scale-in on confirmed volume-backed breakouts. For longer-term holders, watch R&D-to-revenue at 63.06% as evidence of product pipeline investment.
Final Thoughts
We view 2228.HK stock as a growth‑oriented healthcare AI play trading at HK$9.89 pre-market on 17 Mar 2026. Fundamentals show high R&D intensity and strong liquidity, while cash flow and receivables remain weak. Technicals favor a trend but with oversold momentum. Meyka AI’s model suggests a HK$11.76 quarterly target, implying +18.91% upside, and a yearly projection of HK$10.66, implying +7.74% upside versus today. Use earnings on 25 Mar 2026 as a catalyst filter. Forecasts are model projections and not guarantees. We present these data-driven insights for portfolio context and risk management. For more tools, see our Meyka AI-powered market analysis and the XtalPi investor site source and HKEX main site source.
FAQs
What is the current price and market cap of 2228.HK stock?
2228.HK stock trades at HK$9.89 pre-market with a market cap of HK$40,882,031,730.00. Volume today is 47,386,783.00 shares and the 52-week range is HK$3.85 to HK$15.12.
What are Meyka AI’s short-term and yearly forecasts for 2228.HK stock?
Meyka AI’s forecast model projects HK$9.26 monthly, HK$11.76 quarterly, and HK$10.66 yearly for 2228.HK stock. Model outputs imply -6.37% monthly and +7.74% yearly moves versus current price. Forecasts are not guarantees.
What are the main risks for investors in 2228.HK stock?
Main risks include negative operating cash flow per share (HK$-0.11), long receivable days (268.35), and high price-to-sales (52.87). Execution delays or weak bookings could pressure the stock.
When is XtalPi’s next earnings release and why does it matter to 2228.HK stock?
XtalPi’s earnings announcement is scheduled for 25 Mar 2026. Earnings will update guidance, cash flow visibility, and commercialization milestones, any of which could move 2228.HK stock materially.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)